"TBSF" (20%) Human Albumin Solution

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

Albumin, Quantity: 200 g/L

Tilgjengelig fra:

CSL Behring Australia Pty Ltd

INN (International Name):

Albumin

Legemiddelform:

Injection, solution

Sammensetning:

Excipient Ingredients: octanoate; sodium

Administreringsrute:

Intravenous

Enheter i pakken:

50mL, 100mL

Klasse:

Medicine Listed (Export Only)

Resept typen:

(S1) This Schedule is intentionally blank

Indikasjoner:

Hypoproteinaemia in the acutely ill patient TBSF (20%) Human Albumin Solution is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy. Shock. TBSF (20%) Human Albumin Solution may be used for the resuscitation of patients in shock due to acute loss of blood or plasma, but 4 - 5% human albumin is preferred when available. Burns. Extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins resulting in hypovolaemic shock and circulatory failure.

Produkt oppsummering:

Visual Identification: Clear, slightly viscous almost colourless, yellow or green; Container Type: Vial; Container Life Time: 4 Years; Container Temperature: Store below 30 degrees Celsius

Autorisasjon status:

Listed (Export Only)

Autorisasjon dato:

2006-03-01